The British drug and Health Products Administration approved the use of the new coronavirus vaccine developed by valneva company of France in the UK on the 14th. This is the sixth new coronavirus vaccine approved in the UK, and it is also the first time that the whole virus inactivated new coronavirus vaccine has been approved in the UK. The British drug and health products administration said in a statement on the same day that in view of the safety, quality and effectiveness standards of varneva vaccine in the UK, it decided to approve the vaccine for people aged 18 to 50, with an interval of at least 28 days between the first and second doses. The statement said that the UK drug and health products administration was the first organization in the world to approve the vaccine. Varneva vaccine requires two doses, and its storage temperature is 2 to 8 degrees Celsius, which is similar to the refrigeration temperature of household refrigerators. Therefore, it is suitable for countries that cannot store neocoronavirus vaccine at very low temperatures. The five new coronavirus vaccines previously approved in the UK are Pfizer vaccine, Modena vaccine, Johnson & Johnson vaccine, Novavax vaccine and AstraZeneca vaccine in the UK. Johnson & Johnson and AstraZeneca vaccines are adenovirus vector vaccines, Modena and Pfizer vaccines are mRNA (messenger RNA) vaccines, and Novavax vaccine is recombinant protein vaccine. According to the latest epidemic data released by the British government, as of the 14th, there had been 21747638 confirmed new coronavirus cases and 171396 deaths in the country. More than 92% of people aged 12 and over had received at least one dose of new coronavirus vaccine, more than 86% had received at least two doses of vaccine, and about 67% had received booster shots. (Xinhua News Agency)